The decision to expand the development plan follows recently reported promising preclinical findings demonstrating that ...

The market regulator has once again extended the deadline for registered entities (REs) to adopt Cybersecurity and Cyber Resilience Framework (CSCRF), except for market infrastruc ...

Sebi has extended the deadline for regulated entities to adopt a cybersecurity framework to June 2025, citing requests for ...

SEBI extends compliance deadline for Cybersecurity and Cyber Resilience Framework until June 30, 2025, except for certain entities.

These days, along with the relief of having a stable job, comes a load of added stress- with work pressure mounting up day on ...

Markets regulator Sebi on Friday extended the timeline by three months till June for regulated entities to adopt and implement cybersecurity and cyber resilience framework.

Good morning, Mike Shildt got to break out one of his favorite expressions one game into the season, and he did not waste any ...

Adding immunotherapy to new KRAS inhibitors boosted responses in preclinical models, setting the stage for future trials of the combination strategy.

Sebi has extended the deadline by three months for regulated entities to implement a cybersecurity and cyber resilience ...

QTX3544 is an oral, G12V-preferring, dual ON/OFF state, multi-KRAS inhibitor currently being evaluated in a Phase 1 clinical trial in patients with KRASG12V mutations. The mitogen-activated ...

RAS is the most frequently mutated oncogene in cancer, with KRAS mutations occurring in nearly one-quarter of all human cancers. RAS mutations impair the ability of RAS to convert from its active ...